| HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant (NCT03326921) | Fred Hutchinson Cancer Center | 2018-02-23 |
| Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology (NCT06335277) | European Institute of Oncology | 2018-02-22 |
| A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia (NCT03410875) | Memorial Sloan Kettering Cancer Center | 2018-02-09 |
| Exercise as an Immune Adjuvant for Allogeneic Cell Therapies (NCT06643221) | University of Arizona | 2018-01-24 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation (NCT03373526) | Daniel Godoy Martinez | 2017-11-11 |
| Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies (NCT03883672) | Saint-Louis Hospital, Paris, France | 2017-11-10 |
| A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia (NCT03330691) | Seattle Children's Hospital | 2017-11-03 |
| WB-EMS and Nutrition in Patients With Hematological Malignancies (NCT03556748) | University of Erlangen-Nürnberg Medical School | 2017-11-01 |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL (NCT03319901) | Dana-Farber Cancer Institute | 2017-10-30 |
| Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL (NCT02656147) | Beijing Doing Biomedical Co., Ltd. | 2017-10-01 |
| CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies (NCT03312205) | Hebei Senlang Biotechnology Inc., Ltd. | 2017-08-29 |
| A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology (NCT03126045) | Centre Hospitalier Universitaire de Saint Etienne | 2017-08-22 |
| Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies (NCT03262298) | Affiliated Hospital to Academy of Military Medical Sciences | 2017-08-20 |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) (NCT03016130) | University of Florida | 2017-08-18 |
| Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia (NCT02730884) | M.D. Anderson Cancer Center | 2017-08-16 |
| Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing (NCT03226704) | National Cancer Institute (NCI) | 2017-08-14 |
| Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309) | University Health Network, Toronto | 2017-08-03 |
| A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma (NCT03244306) | Seattle Children's Hospital | 2017-07-27 |
| Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS (NCT03066648) | Novartis Pharmaceuticals | 2017-07-06 |
| Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy (NCT03144583) | Sara V. Latorre | 2017-06-15 |
| Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) (NCT03173417) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2017-05-23 |
| Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia (NCT03281746) | Virginia Commonwealth University | 2017-05-19 |
| Laboratory Studies Into the Pathology of Leukaemia (NCT03233763) | Royal Marsden NHS Foundation Trust | 2017-04-24 |
| TKI Discontinuation in CML Patients of China (NCT03251352) | Shenzhen Second People's Hospital | 2017-03-01 |
| Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors (NCT03052777) | University of Alberta | 2017-02-21 |
| Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes (NCT03058588) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-02-09 |
| CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies (NCT03121625) | Hebei Senlang Biotechnology Inc., Ltd. | 2016-12-26 |
| Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) (NCT02773732) | University of Florida | 2016-12-16 |
| Pre-existing Kinase Domain Mutations in Ph-positive Leukemias (NCT02643888) | St. Anna Kinderkrebsforschung | 2016-12-01 |
| Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials (NCT02948413) | National Institutes of Health Clinical Center (CC) | 2016-11-10 |
| Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment (NCT02932280) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT (NCT02942173) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-10-01 |
| Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia (NCT02709083) | Emory University | 2016-10-01 |
| A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies (NCT02958410) | Southwest Hospital, China | 2016-10-01 |
| A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies (NCT02954445) | Southwest Hospital, China | 2016-10-01 |
| A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies (NCT02937103) | Southwest Hospital, China | 2016-10-01 |
| A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia (NCT02723994) | Incyte Corporation | 2016-09-30 |
| Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) (NCT02910583) | Pharmacyclics LLC. | 2016-09-28 |
| Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) (NCT02829840) | M.D. Anderson Cancer Center | 2016-09-01 |
| Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) (NCT02668653) | Daiichi Sankyo | 2016-09-01 |
| CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation (NCT02910752) | Shanghai Jiao Tong University School of Medicine | 2016-09-01 |
| Safety and Efficacy Evaluation of IM19 CAR-T Cells (NCT03142646) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2016-08-30 |
| Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome (NCT02859389) | St. Jude Children's Research Hospital | 2016-08-18 |
| Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant (NCT02477878) | Bellicum Pharmaceuticals | 2016-07-01 |
| Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation (NCT02784561) | Chinese PLA General Hospital | 2016-07-01 |
| Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies (NCT02795182) | BeiGene | 2016-06-29 |
| Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem (NCT02748850) | Assistance Publique Hopitaux De Marseille | 2016-06-08 |
| Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy (NCT02796365) | Henry Ford Health System | 2016-06-01 |
| LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02652871) | M.D. Anderson Cancer Center | 2016-05-09 |
| Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT (NCT02786485) | Bellicum Pharmaceuticals | 2016-05-01 |
| NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents (NCT02763475) | Instituto de Investigación Hospital Universitario La Paz | 2016-05-01 |
| Early Life Exposures in Agriculture (NCT02743481) | National Cancer Institute (NCI) | 2016-04-14 |
| Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) (NCT02599649) | M.D. Anderson Cancer Center | 2016-03-21 |
| Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation (NCT02719821) | University of Wisconsin, Madison | 2016-03-01 |
| A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies (NCT02710149) | Southwest Hospital, China | 2016-03-01 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL (NCT03564704) | Nanfang Hospital, Southern Medical University | 2016-02-14 |
| Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL (NCT03564470) | Nanfang Hospital, Southern Medical University | 2016-02-14 |
| Medical Treatment Decision Making Using Adaptive Conjoint Analysis (NCT02608307) | St. Jude Children's Research Hospital | 2016-02-09 |
| Post-transfusion Platelet Count (NCT02601131) | Region Skane | 2016-02-01 |
| Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients (NCT05808803) | Zhongnan Hospital | 2016-01-01 |
| Interferon-α After DLI for the Prevention of Relapse (NCT02568241) | Peking University People's Hospital | 2015-12-01 |
| Illness Management and Parental Adjustment to Cancer Treatment (NCT02505165) | Children's Hospital Medical Center, Cincinnati | 2015-11-19 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02419469) | M.D. Anderson Cancer Center | 2015-11-13 |
| Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis (NCT02593123) | Virginia Commonwealth University | 2015-11-04 |
| Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia (NCT02735291) | Sinobioway Cell Therapy Co., Ltd. | 2015-11-01 |
| Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation (NCT02598752) | Memorial Sloan Kettering Cancer Center | 2015-11-01 |
| Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy (NCT02638467) | University of Milano Bicocca | 2015-11-01 |
| Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant (NCT01617473) | Peking University People's Hospital | 2015-10-01 |
| Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL (NCT02799550) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2015-10-01 |
| Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) (NCT02469415) | M.D. Anderson Cancer Center | 2015-09-30 |
| Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis (NCT02385110) | M.D. Anderson Cancer Center | 2015-09-23 |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) (NCT02441803) | M.D. Anderson Cancer Center | 2015-09-14 |
| Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome (NCT02530463) | M.D. Anderson Cancer Center | 2015-09-08 |
| A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers (NCT02409121) | University of Michigan Rogel Cancer Center | 2015-09-01 |
| Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors (NCT02192333) | Fred Hutchinson Cancer Center | 2015-08-03 |
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) (NCT02583815) | University of Texas Southwestern Medical Center | 2015-08-01 |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention (NCT02423915) | M.D. Anderson Cancer Center | 2015-07-30 |
| Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study (NCT02546791) | Bristol-Myers Squibb | 2015-07-22 |
| Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02420938) | M.D. Anderson Cancer Center | 2015-07-01 |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT02464657) | M.D. Anderson Cancer Center | 2015-07-01 |
| Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02481297) | M.D. Anderson Cancer Center | 2015-06-23 |
| A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML (NCT02403310) | H. Lee Moffitt Cancer Center and Research Institute | 2015-06-18 |
| Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia (NCT02473523) | St. Jude Children's Research Hospital | 2015-06-01 |
| Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure (NCT02159872) | M.D. Anderson Cancer Center | 2015-05-18 |
| An Open-label Phase II Study of Lorvotuzumab Mertansine (NCT02420873) | M.D. Anderson Cancer Center | 2015-05-12 |
| Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT02141477) | M.D. Anderson Cancer Center | 2015-05-06 |
| Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children (NCT02484261) | Reuven Schore | 2015-05-01 |
| Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes (NCT02450708) | Memorial Sloan Kettering Cancer Center | 2015-05-01 |
| African American Cancer Clinical Trial Decisions: Testing Tailored Messages (NCT02356549) | Virginia Commonwealth University | 2015-05-01 |
| Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) (NCT02347878) | Sun Yat-sen University | 2015-04-01 |
| Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission (NCT02302846) | M.D. Anderson Cancer Center | 2015-03-20 |
| An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T) (NCT02225574) | M.D. Anderson Cancer Center | 2015-03-11 |
| Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma (NCT02280525) | M.D. Anderson Cancer Center | 2015-03-05 |
| Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation (NCT02210065) | M.D. Anderson Cancer Center | 2015-03-03 |
| Study of TCP-ATRA for Adult Patients With AML and MDS (NCT02273102) | University of Miami | 2015-03-02 |
| Physical Activity as Self-Management Approach to Improve Health Outcomes in AML (NCT02584296) | Virginia Commonwealth University | 2015-03-01 |
| Lactation Outcomes Among Survivors of Pediatric Cancer (NCT02399956) | St. Jude Children's Research Hospital | 2015-03-01 |
| Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia (NCT02345382) | Bayer | 2015-02-19 |
| Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source (NCT02167958) | Rafic Farah, MD | 2015-02-11 |